Последние новости

Реклама

В.В СКЛЯРЕВИЧ. Антибактериальные лекарственые средства. Методы стандартизации препаратов. Раздел 2

В.В СКЛЯРЕВИЧ. Антибактериальные лекарственые средства. Методы стандартизации препаратов. Страница 132

Mandell G. L. (ed). op. cit..

14 .Andes D., Craig W. A. In vitro activities of amoxicillin and amoxicillin- clavulanate against Streptococcus pneumoniae: Application to breakpoint determination // Antimicrob Agents Chemother. — 1998. — Vol. 42. - P. 2375-2379.

15. Dudley M. N., Ambrose P. G. Monte Carlo Simulation of new cefotaxime, ceftriaxone and cefepime susceptibility breakpoints for S. pneumoniae, including strains with reduced susceptibility to penicillin. — In: Abstracts of the 42nd ICAAC, San Diego, CA, Sept. 27—30, 2002. — Abs-635.

16. Petermans W. MIC-based therapies. — BVIKM/SBIMC, Antewerpen, 8 nov 2002.

17. Lode H., Garau J., Grassi C. et al. Treatment of community-acquired pneumonia: a randomized comparison of sparfloxacin, amoxycillin-cla- vulanic acid and erythromycin // Eur. Respir. J. — 1995. — Vol. 8 (12). - P. 1999-2007.

18. O'Doherty B.y Dutchman D. A., Pettit R., Maroli A. Randomized, dou- ble-blind, comparative study of grepafloxacin and amoxycillin in the treatment of patients with community-acquired pneumonia // J. Antimicrob. Chemother. — 1997. — Vol. 40, Suppl. A. — P. 73—81.

19. Genne D., Siegrist H. H., Humair L. et al. Clarithromycin versus amoxi- cillin-clavulanic acid in the treatment of community-acquired pneumonia // Eur. J. Clin. Microbiol. Infect. Dis. — 1997. — Vol. 16 (11). — P. 783-788.

20. Poirier R., Chardon H., Beraud A. et al. Efficacy and tolerability of pris- tinamycin vs amoxicillin-clavulanic acid combination in the treatment of acute community-acquired pneumonia in hospitalized adults // Rev. Pneumol. Clin. - 1997. - Vol. 53 (6). - P. 325-331.

21. Tremolieres F., de Kock F., Pluck N., Daniel R. Trovafloxacin versus high-dose amoxicillin (1 g three times daily) in the treatment of com- munity-acquired bacterial pneumonia // Eur. J. Clin. Microbiol. Infect. Dis. - 1998. - Vol. 17 (6). - P. 447-453.